NOTICES
Notices
The National Cancer
Institute (NCI) Office of Education and Special Initiatives is looking
for patients, family caregivers, and physicians who are interested in
participating in telephone focus groups and in-depth interviews.
This research will ensure that new NCI palliative care-related
educational products meet the needs of a diverse audience.
Please click on the links below to see flyers that describe those who may qualify to participate. To view the contents of these files, you must have Adobe Acrobat Reader software installed. You can download this free software from the Adobe Reader Web page.
If you have any questions, please contact our contractor, Melinda Moyer at ORC Macro (Melinda.K.Moyer@orcmacro.com or 301-572-0475).
Thank you very much
for your assistance and support in this important effort.
The National Cancer Institute (NCI) is a component of
the National Institutes of Health (NIH) in the Department of Health and
Human Services (DHHS). The NCI is the Federal Government's principal
agency for cancer research and training.
NCI's Office of Education and Special Initiatives develops, implements
and evaluates education programs over the entire cancer continuum,
including prevention, screening, diagnosis, treatment, survivorship and
palliative care.
For more information about the NCI, please log on to cancer.gov or call
1-800-4-CANCER (1-800-422-6237).
The DES
Cancer Network is no longer responding directly to email
inquiries. If you have a general
(non-cancer) DES-related question or concern, please contact DES
Action by calling the toll-free information line at 1-800-337-9288
or by sending a message tot desaction@columbus.rr.com.
The Web site address is www.desaction.org.
If your question or concern is cancer-related
please go the University of Chicago, DES Cancer Registry website
at www.obgyn.bsd.uchicago.edu/registry
or contact them directly by phone at 1-773-703-6671 or by email at danderso1@babies.bsd.uchicago.edu.
If you need to talk to someone about support for yourself or a family member, the moderators of both of the Web sites above will direct you to a DES-related clear cell cancer survivor.
 |
|
 |
|